The Global Stents Market was valued at USD 14.2 billion in 2024 and is projected to reach USD 21.7 billion by 2030, expanding at a CAGR of 7.3% from 2025 to 2030.
Stents are medical devices used to open blocked or narrowed blood vessels, ureters, or other tubular structures in the body. They are commonly employed in the treatment of cardiovascular diseases, urological conditions, and other ailments requiring intervention.
The market is witnessing growth due to the rising prevalence of chronic conditions such as cardiovascular diseases, advancements in stent technologies, and an increase in minimally invasive procedures. The development of bioresorbable and drug-eluting stents has further revolutionized the sector by improving patient outcomes and reducing complication risks.
Key Market Insights
Coronary stents dominate the product segment, holding more than 55% of the market share in 2024, driven by the rising incidence of cardiovascular diseases globally.
Drug-eluting stents (DES) are the leading subcategory in terms of material and technology, offering reduced restenosis rates and superior clinical outcomes.
The hospital end-user segment accounted for the largest share, exceeding 60% in 2024, owing to the high number of procedures performed in this setting.
North America leads the market, driven by advanced healthcare infrastructure and a high prevalence of coronary artery disease.
Emerging markets in Asia-Pacific are experiencing robust growth due to rising healthcare expenditures and increasing awareness of advanced treatment options.
The demand for bioabsorbable stents is increasing, supported by their ability to eliminate long-term complications associated with permanent stents.
Global Stents Market Drivers
1. Rising Prevalence of Cardiovascular Diseases is driving the market growth
The global burden of cardiovascular diseases (CVDs) is a major driver of the stents market. According to the World Health Organization (WHO), CVDs account for nearly 17.9 million deaths annually, representing 32% of all global deaths. Lifestyle changes, unhealthy diets, and sedentary habits are contributing to this rise, especially in emerging economies.
Stents, particularly coronary stents, are crucial in treating conditions like atherosclerosis and coronary artery disease. The increasing adoption of minimally invasive procedures for treating CVDs is further propelling market growth.
2. Technological Advancements in Stents is driving the market growth
Technological innovations in stent design and material have significantly enhanced their safety and efficacy. The development of drug-eluting stents (DES) has reduced restenosis rates compared to traditional bare-metal stents, improving patient outcomes.
Additionally, the advent of bioresorbable stents represents a breakthrough in stent technology. These stents dissolve over time, reducing the risk of long-term complications. Ongoing research and development activities are expected to drive the adoption of advanced stents, fostering market growth.
3. Growing Demand for Minimally Invasive Procedures is driving the market growth
Minimally invasive surgeries are gaining traction globally due to their advantages, such as shorter recovery times, reduced pain, and lower complication rates. Stenting procedures, particularly percutaneous coronary intervention (PCI), are widely preferred for treating vascular blockages.
The rising preference for these procedures is supported by advancements in imaging technologies and catheter-based systems, which have improved the precision and safety of stent placements. This trend is expected to continue, boosting the demand for stents.
Global Stents Market Challenges and Restraints
1. High Costs of Stent Procedures and Devices is restricting the market growth
The high cost of stents, particularly advanced variants like drug-eluting and bioresorbable stents, poses a significant challenge to market growth. In developing and underdeveloped regions, the affordability of stenting procedures remains a concern due to limited healthcare coverage and low-income levels.
Efforts to reduce stent prices through government initiatives and local manufacturing are underway. However, cost-related barriers could still hinder the widespread adoption of stents in economically weaker regions.
2. Risk of Complications and Device Failures is restricting the market growth
Although stents have revolutionized the treatment of vascular diseases, they are not without risks. Potential complications include stent thrombosis, restenosis, and infections. Device malfunctions, though rare, can lead to severe consequences, necessitating additional interventions.
Manufacturers are focusing on improving the biocompatibility and design of stents to address these issues. Despite these advancements, concerns over safety and efficacy may impact patient and physician confidence, affecting market growth.
Market Opportunities
The stents market offers significant growth opportunities, particularly in emerging economies where healthcare infrastructure is improving rapidly. Governments and private organizations are investing in expanding access to advanced medical technologies, driving the adoption of stents.
Additionally, the increasing focus on value-based healthcare is creating opportunities for cost-effective stent solutions. Manufacturers introducing affordable stents without compromising on quality are well-positioned to capture market share in price-sensitive regions.
The development of personalized stents, tailored to the specific anatomical and clinical needs of patients, represents another growth avenue. These innovations, coupled with advancements in imaging and deployment technologies, are expected to transform the stents market in the coming years.
STENTS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2024 - 2030 |
|
Base Year |
2024 |
|
Forecast Period |
2025 - 2030 |
|
CAGR |
7.3% |
|
Segments Covered |
By Product type, Material, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Terumo Corporation, Cook Medical, Biotronik SE & Co. KG, C. R. Bard, Inc. (a BD Company), MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd. |
Coronary Stents
Bare-Metal Stents
Drug-Eluting Stents (DES)
Bioresorbable Stents
Peripheral Stents
Ureteral Stents
Others
Coronary stents represent the largest product segment within the stent market, driven by the high prevalence of coronary artery disease (CAD) and the widespread adoption of drug-eluting stents (DES). CAD, a condition characterized by the buildup of plaque in the coronary arteries, remains a leading cause of morbidity and mortality worldwide. Percutaneous coronary intervention (PCI), a minimally invasive procedure involving the deployment of a stent to open blocked or narrowed coronary arteries, has become a standard treatment for CAD. Drug-eluting stents have revolutionized the field of interventional cardiology by delivering a therapeutic dose of medication to the arterial wall, inhibiting cell proliferation and reducing the risk of restenosis. These devices offer superior clinical outcomes compared to bare-metal stents, making them the preferred choice for most patients undergoing PCI. The increasing availability of advanced DES with improved drug delivery systems and biocompatibility has further fueled the growth of this segment. As the global population ages and the prevalence of cardiovascular risk factors continues to rise, the demand for coronary stents is expected to remain strong, driving significant growth in the overall stent market.
Metallic
Polymer
Hybrid
Metallic stents dominate the material segment due to their durability and affordability. However, polymer-based stents are gaining popularity, supported by advancements in biodegradable materials.
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Hospitals are the primary end-users of stents, dominating the market due to their specialized infrastructure, skilled personnel, and comprehensive treatment capabilities. These institutions are equipped with advanced catheterization laboratories and experienced interventional cardiologists who perform complex percutaneous coronary interventions (PCIs) to treat coronary artery disease. Hospitals often have dedicated cardiac units to monitor and care for patients post-procedure, ensuring optimal recovery and minimizing complications. The rising prevalence of cardiovascular diseases, such as coronary artery disease and peripheral arterial disease, has significantly contributed to the demand for stenting procedures in hospitals. These institutions are well-positioned to handle the complex needs of patients with these conditions, offering a range of diagnostic and therapeutic services, including angiography, angioplasty, and stent implantation
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
North America holds the largest share of the global stents market, with the United States being the primary contributor. Factors such as advanced healthcare infrastructure, high adoption of innovative technologies, and favorable reimbursement policies are driving market growth in the region.
Asia-Pacific, on the other hand, is the fastest-growing region, supported by increasing healthcare investments, rising awareness of minimally invasive treatments, and the growing prevalence of cardiovascular diseases. Countries like China and India are emerging as lucrative markets due to their large patient populations and improving access to advanced medical care.
COVID-19 Impact Analysis
The COVID-19 pandemic had a mixed impact on the global stents market. While elective procedures, including non-urgent stenting, were delayed during the initial phase of the pandemic, the demand for stents rebounded as healthcare systems adapted to the new normal. The pandemic underscored the importance of efficient healthcare delivery, accelerating investments in minimally invasive procedures and advanced medical devices. Moreover, the increased focus on improving healthcare infrastructure in response to the pandemic is expected to have a positive long-term impact on the stents market.
Latest Trends/Developments
Advances in Bioresorbable Stents: The development of stents that dissolve after restoring blood flow is gaining momentum, reducing the risk of long-term complications such as restenosis and thrombosis. These innovative devices offer significant advantages over traditional metallic stents, as they eliminate the need for permanent implants and minimize the potential for late adverse events. As bioresorbable polymers continue to evolve, these stents are becoming increasingly effective and safe, paving the way for a new era of minimally invasive cardiovascular interventions. Combining metallic and polymer materials is improving the biocompatibility and flexibility of stents, enhancing their performance in complex cases. These hybrid stents offer a balance between the strength and durability of metal and the flexibility and biocompatibility of polymers. By strategically incorporating metallic components into polymer-based stents, manufacturers can optimize device performance, reduce the risk of complications, and improve long-term outcomes for patients. Real-time imaging systems, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are being used to optimize stent placement, improving procedural success rates. These advanced imaging modalities provide detailed visualization of the coronary arteries, enabling precise stent deployment and ensuring optimal blood flow restoration. By integrating imaging technologies with stent delivery systems, physicians can minimize the risk of complications and achieve superior clinical results. Manufacturers are expanding their presence in developing regions to cater to the growing demand for affordable stents. As healthcare systems in these countries continue to improve, there is a rising need for effective and cost-effective cardiovascular interventions. By offering innovative stent technologies at competitive prices, manufacturers can help address the unmet needs of patients in emerging markets and contribute to the global fight against cardiovascular disease.
Key Players
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
B. Braun Melsungen AG
Terumo Corporation
Cook Medical
Biotronik SE & Co. KG
C. R. Bard, Inc. (a BD Company)
MicroPort Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The market was valued at USD 14.2 billion in 2024 and is projected to reach USD 21.7 billion by 2030, growing at a CAGR of 7.3%.
Key drivers include the rising prevalence of cardiovascular diseases, advancements in stent technologies, and the growing demand for minimally invasive procedures
Segments include Product Type (Coronary Stents, Peripheral Stents, Ureteral Stents, Others), Material (Metallic, Polymer, Hybrid), and End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics).
North America dominates with over 40% of the market share, driven by advanced healthcare infrastructure and high adoption of innovative technologies.
Leading players include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, and others.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
